Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 139,229 182,993 316,353 638,922
Total Sell Value $12,316,080 $16,513,389 $28,948,007 $60,375,372
Total People Sold 5 5 6 8
Total Sell Transactions 11 15 24 57
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 1303
  Page 20 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-05-16 4 OE $9.86 $147,900 D/D 15,000 183,691     -
   Lawlis V Bryan Director   –       •      –    2012-05-15 4/A S $38.51 $342,769 D/D (8,900) 10,900     -
   Lawlis V Bryan Director   –       •      –    2012-05-15 4 S $38.51 $342,769 D/D (8,900) 13,400     -
   Lawlis V Bryan Director   –       •      –    2012-05-15 4 OE $14.39 $92,096 D/D 6,400 19,800     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2012-05-15 4 S $38.64 $386,373 D/D (10,000) 59,030     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2012-05-15 4 OE $17.33 $173,300 D/D 10,000 69,030     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2012-05-14 4 AS $38.09 $961,717 D/D (25,250) 41,089     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2012-05-14 4 OE $14.39 $591,128 D/D 25,250 66,339     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-05-14 4 S $38.13 $571,893 D/D (15,000) 168,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-05-14 4 OE $9.86 $147,900 D/D 15,000 183,691     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-05-12 5 D $38.00 $21,812 D/D (574) 15,036     -
   Bienaime Jean Jacques Chief Business Officer   •       •      –    2012-05-12 5 D $38.00 $297,160 D/D (7,820) 149,446     -
   Davis George Eric SVP, Chief Commercial Of   •       –      –    2012-05-12 5 D $38.00 $29,298 D/D (771) 46,200     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-05-12 5 D $0.00 $0 D/D (1,101) 46,497     -
   Wood Mark VP, Human Resources   •       –      –    2012-05-12 5 D $38.00 $60,382 D/D (1,589) 23,116     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-05-12 4 OE $0.00 $0 D/D 1,562 15,246     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-05-11 4 S $38.01 $969,656 D/D (25,500) 168,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-05-11 4 OE $6.46 $212,500 D/D 25,000 194,191     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2012-05-11 4 S $37.07 $989,348 D/D (26,160) 59,030     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2012-05-11 4 OE $14.39 $324,480 D/D 21,530 68,340     -
   Davis George Eric SVP, General Counsel   •       –      –    2012-05-11 4 S $37.07 $1,604,029 D/D (42,309) 51,322     -
   Davis George Eric SVP, General Counsel   •       –      –    2012-05-11 4 OE $14.39 $575,600 D/D 40,000 91,322     -
   Wood Mark VP, Human Resources   •       –      –    2012-05-11 4 AS $38.00 $92,606 D/D (2,437) 31,114     -
   Wood Mark VP, Human Resources   •       –      –    2012-05-11 4 OE $26.49 $64,556 D/D 2,437 33,551     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2012-05-08 4 A $0.00 $0 D/D 16,000 63,685     -
  1303 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 20 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us